U.S. Court Denies Sequenom Inc.'s Preliminary Injunction Against Ariosa Diagnostics, Inc.

Published: Jul 09, 2012

Sequenom Inc., a life sciences company providing innovative genetic analysis solutions, has confirmed that the United States District Court for the Northern District of California has denied a motion by Sequenom for a preliminary injunction against Ariosa Diagnostics. “While obviously a disappointing preliminary outcome in our efforts to enforce an issued US patent against infringement, yesterday's decision is by no means a final ruling on the infringement or the validity of the '540 patent, but is one step in a long process to enforce our patent and protect our proprietary rights in the non-invasive prenatal testing marketplace,” said Harry F Hixson, Jr., PhD, chairman and CEO, Sequenom, Inc.

Back to news